News & Events about Igm Biosciences Inc.
Medivir to present at the Redeye Fight Cancer Day Medivir to present at the Redeye Fight Cancer Day PR Newswire STOCKHOLM, Jan. 16, 2023 STOCKHOLM, Jan. 16, 2023 /PRNewswire/ --Medivir AB (Nasdaq Stockholm: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in...
Initial Data from Phase 1 combination with FOLFIRI shows promising activity in heavily pretreated metastatic colorectal cancer patients Encouraging safety profile in combination with FOLFIRI chemotherapy Randomized combination trial in second-line colorectal cancer patients to initiate in Q1 2023 ...
Tickeron - Technical Analysis
1month ago
For the last three days, A.I.dvisor has detected that IGMS's AroonDown red line is above 70 while the AroonUp green line is below 30 for three straight days. This move could indicate a strong downtrend ahead for IGMS, and traders may view it as a Sell signal for the next month. Traders may consider ...
IGM Biosciences, Inc. (NASDAQ:IGMS Get Rating) was the recipient of a significant decline in short interest in the month of November. As of November 30th, there was short interest totalling 3,230,000 shares, a decline of 9.3% from the November 15th total of 3,560,000 shares. Currently, 18.7...
IGM Biosciences, Inc. (NASDAQ:IGMS Get Rating) was the recipient of a significant decline in short interest in the month of November. As of November 30th, there was short interest totalling 3,230,000 shares, a decline of 9.3% from the November 15th total of 3,560,000 shares. Currently, 18.7% of the ...